Published in Am J Physiol Endocrinol Metab on February 01, 2001
Systemic β-adrenergic stimulation of thermogenesis is not accompanied by brown adipose tissue activity in humans. Diabetes (2012) 1.45
Glucose and pyruvate metabolism in severe chronic obstructive pulmonary disease. J Appl Physiol (1985) (2011) 0.83
Cachexia in chronic obstructive pulmonary disease: new insights and therapeutic perspective. J Cachexia Sarcopenia Muscle (2015) 0.79
Outcomes for COPD pharmacological trials: from lung function to biomarkers. Eur Respir J (2008) 5.38
Effect of sibutramine on weight maintenance after weight loss: a randomised trial. STORM Study Group. Sibutramine Trial of Obesity Reduction and Maintenance. Lancet (2001) 3.60
Recommendations on the use of exercise testing in clinical practice. Eur Respir J (2007) 3.15
Short- and long-term efficacy of a community-based COPD management programme in less advanced COPD: a randomised controlled trial. Thorax (2009) 3.12
Weight loss is a reversible factor in the prognosis of chronic obstructive pulmonary disease. Am J Respir Crit Care Med (1998) 3.09
Evidence for a relation between metabolic derangements and increased levels of inflammatory mediators in a subgroup of patients with chronic obstructive pulmonary disease. Thorax (1996) 2.33
Obesity and the lung: 5. Obesity and COPD. Thorax (2008) 2.22
Weekly subcutaneous pegylated recombinant native human leptin (PEG-OB) administration in obese men. J Clin Endocrinol Metab (2000) 2.19
Validity of the Physical Activity Scale for the Elderly (PASE): according to energy expenditure assessed by the doubly labeled water method. J Clin Epidemiol (1997) 2.09
Impairment of quality of life: rheumatoid arthritis versus sarcoidosis. Neth J Med (1999) 2.03
The impact of aging and smoking on the future burden of chronic obstructive pulmonary disease: a model analysis in the Netherlands. Am J Respir Crit Care Med (2001) 1.96
Determinants of health-related quality of life in patients with chronic obstructive pulmonary disease. Thorax (1996) 1.94
Systemic anti-inflammatory mediators in COPD: increase in soluble interleukin 1 receptor II during treatment of exacerbations. Thorax (2001) 1.94
Usefulness of lactate dehydrogenase and its isoenzymes as indicators of lung damage or inflammation. Eur Respir J (1996) 1.91
The effects of increasing exercise intensity on muscle fuel utilisation in humans. J Physiol (2001) 1.91
Inflammatory cytokines inhibit myogenic differentiation through activation of nuclear factor-kappaB. FASEB J (2001) 1.88
Folate intake of the Dutch population according to newly established liquid chromatography data for foods. Am J Clin Nutr (2001) 1.87
Prevalence and characteristics of nutritional depletion in patients with stable COPD eligible for pulmonary rehabilitation. Am Rev Respir Dis (1993) 1.87
The role of low-fat diets in body weight control: a meta-analysis of ad libitum dietary intervention studies. Int J Obes Relat Metab Disord (2000) 1.82
Body composition and exercise performance in patients with chronic obstructive pulmonary disease. Thorax (1991) 1.79
Factors contributing to alterations in skeletal muscle and plasma amino acid profiles in patients with chronic obstructive pulmonary disease. Am J Clin Nutr (2000) 1.73
Plasma insulin responses after ingestion of different amino acid or protein mixtures with carbohydrate. Am J Clin Nutr (2000) 1.72
A new validated endurance performance test. Med Sci Sports Exerc (1996) 1.68
Association of fatigue with an acute phase response in sarcoidosis. Eur Respir J (1999) 1.62
Comparison of corridor and treadmill walking in patients with severe chronic obstructive pulmonary disease. Phys Ther (1990) 1.61
Long-term outcome of pulmonary rehabilitation in patients with COPD. Chest (1997) 1.60
Skeletal muscle dysfunction in chronic obstructive pulmonary disease and chronic heart failure: underlying mechanisms and therapy perspectives. Am J Clin Nutr (2000) 1.58
The prevalence of selected physical activities and their relation with coronary heart disease risk factors in elderly men: the Zutphen Study, 1985. Am J Epidemiol (1991) 1.57
Changes in fat oxidation in response to a high-fat diet. Am J Clin Nutr (1997) 1.56
Increased resting energy expenditure and weight loss are related to a systemic inflammatory response in lung cancer patients. J Clin Oncol (1995) 1.56
Blood glucose and meal patterns in time-blinded males, after aspartame, carbohydrate, and fat consumption, in relation to sweetness perception. Br J Nutr (1999) 1.56
Cytokine-induced activation of nuclear factor-kappa B is inhibited by hydrogen peroxide through oxidative inactivation of IkappaB kinase. J Biol Chem (2001) 1.55
Do nutrient-gut-microbiota interactions play a role in human obesity, insulin resistance and type 2 diabetes? Obes Rev (2010) 1.53
Postoperative pulmonary function abnormalities after coronary artery bypass surgery. Respir Med (1992) 1.53
Physical activity and 10-year mortality from cardiovascular diseases and all causes: The Zutphen Elderly Study. Arch Intern Med (1998) 1.53
Dual-energy X-ray absorptiometry in the clinical evaluation of body composition and bone mineral density in patients with chronic obstructive pulmonary disease. Am J Clin Nutr (1998) 1.51
Possible involvement of the adipose tissue renin-angiotensin system in the pathophysiology of obesity and obesity-related disorders. Obes Rev (2003) 1.50
Weight loss and low body cell mass in males with lung cancer: relationship with systemic inflammation, acute-phase response, resting energy expenditure, and catabolic and anabolic hormones. Clin Sci (Lond) (1999) 1.49
Measurement of resting energy expenditure in a clinical setting. Clin Nutr (1990) 1.48
Quality of life and depressive symptoms in patients suffering from sarcoidosis. Sarcoidosis Vasc Diffuse Lung Dis (1998) 1.47
Reference values for maximum work capacity in relation to body composition in healthy Dutch children. Eur Respir J (1997) 1.45
Evaluation of quality of life in sarcoidosis patients. Respir Med (1998) 1.40
Tissue depletion and health related quality of life in patients with chronic obstructive pulmonary disease. Respir Med (2000) 1.38
Skeletal muscle weakness is associated with wasting of extremity fat-free mass but not with airflow obstruction in patients with chronic obstructive pulmonary disease. Am J Clin Nutr (2000) 1.38
Carbohydrate-electrolyte feedings improve 1 h time trial cycling performance. Int J Sports Med (1997) 1.32
A dual-respiration chamber system with automated calibration. J Appl Physiol (1985) (1997) 1.32
Nutritional depletion in relation to respiratory and peripheral skeletal muscle function in out-patients with COPD. Eur Respir J (1994) 1.30
Impact of 3-year lifestyle intervention on postprandial glucose metabolism: the SLIM study. Diabet Med (2008) 1.30
Metabolic flexibility in the development of insulin resistance and type 2 diabetes: effects of lifestyle. Obes Rev (2009) 1.28
Effect of calcium from dairy and dietary supplements on faecal fat excretion: a meta-analysis of randomized controlled trials. Obes Rev (2009) 1.27
Peak exercise response in relation to tissue depletion in patients with chronic obstructive pulmonary disease. Eur Respir J (1997) 1.26
Fatty acid oxidation is directly regulated by carbohydrate metabolism during exercise. Am J Physiol (1997) 1.26
Long-term effect of physical activity on energy balance and body composition. Br J Nutr (1992) 1.26
Physiologic effects of nutritional support and anabolic steroids in patients with chronic obstructive pulmonary disease. A placebo-controlled randomized trial. Am J Respir Crit Care Med (1995) 1.25
Plasma free Fatty Acid uptake and oxidation are already diminished in subjects at high risk for developing type 2 diabetes. Diabetes (2001) 1.24
Adipose tissue fatty acid metabolism in insulin-resistant men. Diabetologia (2008) 1.23
Physiological changes and gastro-intestinal symptoms as a result of ultra-endurance running. Eur J Appl Physiol Occup Physiol (1992) 1.22
Acute effects of exercise or sauna on appetite in obese and nonobese men. Physiol Behav (1997) 1.22
Low-grade inflammation can partly explain the association between the metabolic syndrome and either coronary artery disease or severity of peripheral arterial disease: the CODAM study. Eur J Clin Invest (2009) 1.22
Increased leptin concentrations correlate with increased concentrations of inflammatory markers in morbidly obese individuals. Int J Obes Relat Metab Disord (2001) 1.22
Plasma leptin is related to proinflammatory status and dietary intake in patients with chronic obstructive pulmonary disease. Am J Respir Crit Care Med (1999) 1.22
Resting energy expenditure in patients with chronic obstructive pulmonary disease. Am J Clin Nutr (1991) 1.21
Study on Lifestyle Intervention and Impaired Glucose Tolerance Maastricht (SLIM): preliminary results after one year. Int J Obes Relat Metab Disord (2003) 1.21
Production of the acute-phase protein lipopolysaccharide-binding protein by respiratory type II epithelial cells: implications for local defense to bacterial endotoxins. Am J Respir Cell Mol Biol (2000) 1.20
Effects of dietary fat modification on insulin sensitivity and on other risk factors of the metabolic syndrome--LIPGENE: a European randomized dietary intervention study. Int J Obes (Lond) (2010) 1.18
Impaired oxidation of plasma-derived fatty acids in type 2 diabetic subjects during moderate-intensity exercise. Diabetes (2000) 1.18
Quality of life after palliative radiotherapy in non-small cell lung cancer: a prospective study. Int J Radiat Oncol Biol Phys (2000) 1.18
Glucose kinetics during prolonged exercise in highly trained human subjects: effect of glucose ingestion. J Physiol (1999) 1.18
Improvements in glucose tolerance and insulin sensitivity after lifestyle intervention are related to changes in serum fatty acid profile and desaturase activities: the SLIM study. Diabetologia (2006) 1.17
Habitual physical activity in children: methodology and findings in health and disease. Med Sci Sports Exerc (1986) 1.16
Total free living energy expenditure in patients with severe chronic obstructive pulmonary disease. Am J Respir Crit Care Med (1997) 1.16
Ectopic fat storage in the pancreas, liver, and abdominal fat depots: impact on β-cell function in individuals with impaired glucose metabolism. J Clin Endocrinol Metab (2010) 1.16
Relationship between gastro-intestinal complaints and endotoxaemia, cytokine release and the acute-phase reaction during and after a long-distance triathlon in highly trained men. Clin Sci (Lond) (2000) 1.15
Maximizing postexercise muscle glycogen synthesis: carbohydrate supplementation and the application of amino acid or protein hydrolysate mixtures. Am J Clin Nutr (2000) 1.15
Daily physical activity of schoolchildren with spastic diplegia and of healthy control subjects. J Pediatr (1995) 1.15
Asymptomatic brain metastases (BM) in small cell lung cancer (SCLC): MR-imaging is useful at initial diagnosis. J Neurooncol (2000) 1.14
Adverse effects of the indoor environment on respiratory health in primary school children. Environ Res (1995) 1.14
Body composition by bioelectrical-impedance analysis compared with deuterium dilution and skinfold anthropometry in patients with chronic obstructive pulmonary disease. Am J Clin Nutr (1991) 1.13
Carbohydrate ingestion can completely suppress endogenous glucose production during exercise. Am J Physiol (1999) 1.11
Intratracheal instillation of lipopolysaccharide in mice induces apoptosis in bronchial epithelial cells: no role for tumor necrosis factor-alpha and infiltrating neutrophils. Am J Respir Cell Mol Biol (2001) 1.10
Enteral nutrition in intensive care patients: a practical approach. Working Group on Nutrition and Metabolism, ESICM. European Society of Intensive Care Medicine. Intensive Care Med (1998) 1.09
Ingestion of protein hydrolysate and amino acid-carbohydrate mixtures increases postexercise plasma insulin responses in men. J Nutr (2000) 1.09
Use of the doubly labeled water technique in humans during heavy sustained exercise. J Appl Physiol (1985) (1986) 1.08
Intravenous AICAR administration reduces hepatic glucose output and inhibits whole body lipolysis in type 2 diabetic patients. Diabetologia (2008) 1.07
What is a normal red-blood cell mass for professional cyclists? Lancet (1998) 1.07